Eric Volkman

Why AbbVie Stock Flopped on Friday

The market didn’t exactly greet the company’s latest earnings release with open arms. AbbVie‘s (ABBV 4.44%) products are regularly used to help heal the sick, but the company’s stock wasn’t healthy for portfolios on Friday. The company published its latest quarterly earnings release, and investors expressed their displeasure with it by selling out of the…

Read More